# Emgality for Migraine in Breastmilk

> **NCT06085144** · — · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 30 (estimated)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Galcanezumab

## Key facts

- **NCT ID:** NCT06085144
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-26
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06085144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06085144, "Emgality for Migraine in Breastmilk". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06085144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*